Federated Hermes’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-632
Closed -$9.46K 2066
2025
Q3
$9.46K Sell
632
-1,048
-62% -$12.8K ﹤0.01% 1887
2025
Q2
$19.6K Sell
1,680
-1,378
-45% -$12.5K ﹤0.01% 1715
2025
Q1
$22.7K Sell
3,058
-4,912
-62% -$37.8K ﹤0.01% 1711
2024
Q4
$47.8K Sell
7,970
-3,289
-29% -$18.1K ﹤0.01% 1677
2024
Q3
$57.6K Sell
11,259
-46,013
-80% -$200K ﹤0.01% 1631
2024
Q2
$207K Sell
57,272
-1,244,445
-96% -$3.95M ﹤0.01% 1470
2024
Q1
$4.18M Buy
1,301,717
+89,057
+7% +$345K 0.01% 768
2023
Q4
$5.94M Sell
1,212,660
-172,547
-12% -$787K 0.01% 674
2023
Q3
$7.55M Buy
1,385,207
+272,720
+25% +$1.8M 0.02% 598
2023
Q2
$7.46M Sell
1,112,487
-63,569
-5% -$473K 0.02% 606
2023
Q1
$10.4M Sell
1,176,056
-231,130
-16% -$2.04M 0.03% 536
2022
Q4
$10.8M Buy
1,407,186
+5,847
+0.4% +$45.5K 0.03% 522
2022
Q3
$9.98M Buy
1,401,339
+3,806
+0.3% +$35.8K 0.03% 531
2022
Q2
$11.3M Buy
1,397,533
+841,334
+151% +$7.4M 0.03% 525
2022
Q1
$7.72M Buy
+556,199
New +$8.74M 0.02% 672
2021
Q2
Sell
-42,000
Closed -$1.69M 2195
2021
Q1
$1.69M Sell
42,000
-18,088
-30% -$979K ﹤0.01% 1168
2020
Q4
$3.55M Buy
60,088
+18,088
+43% +$933K 0.01% 901
2020
Q3
$2.04M Hold
42,000
﹤0.01% 979
2020
Q2
$2.03M Sell
42,000
-14,296
-25% -$521K 0.01% 993
2020
Q1
$1.56M Buy
56,296
+9,061
+19% +$253K ﹤0.01% 968
2019
Q4
$1.41M Buy
47,235
+5,235
+12% +$150K ﹤0.01% 1141
2019
Q3
$1.3M Sell
42,000
-33,000
-44% -$1.35M ﹤0.01% 1190
2019
Q2
$3.62M Buy
+75,000
New +$3.32M 0.01% 878

Other funds holding ADPT